IREN
IREN Limited
There isn't enough reported data to score IREN yet.
SFNC
Simmons First National Corporation
SFNC's fundamentals are mixed, but it looks expensive: trading at 15x earnings, above its usual 12x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
SFNC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SFNC's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SFNC.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
SFNC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.4x | $13.58 | -42% |
| Forward | 10x | $23.39 | — |
| Fair | 12x | $18.91 | -19% |
| Current | 15x | $23.39 | — |
| Expensive | 16x | $25.35 | +8.4% |
Historical ranges are pointers, not guarantees.
SFNC's PE is in its expensive range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SFNC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SFNC's earnings to grow and its profitability to improve, with its revenue holding steady.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
SFNC has the stronger earnings trend. Trailing diluted EPS is down 347% for IREN versus SFNC up 58%.
SFNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.27 | +41% |
| Q2 2025 | $1.27 | +6.7% |
| Q1 2025 | $1.16 | -13% |
| Q4 2024 | $1.21 | -12% |
| Q3 2024 | $1.02 | -44% |
| Q2 2024 | $1.19 | -43% |
| Q1 2024 | $1.33 | -28% |
| Q4 2023 | $1.38 | -33% |
| Q3 2023 | $1.83 | 0% |
SFNC's earnings per share have fallen from their peak: $1.61 over the past year, against $2.58 in early 2020.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
SFNC has the stronger quarterly revenue trend. Revenue is down 5.1% for IREN versus up 17% for SFNC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
SFNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $248.6M | +16% |
| Q1 2026 | $241.4M | +15% |
| Q4 2025 | $249M | +19% |
| Q2 2025 | $214.2M | +8.6% |
| Q1 2025 | $209.6M | +7.4% |
| Q4 2024 | $208.5M | +17% |
| Q3 2024 | $174.8M | -11% |
| Q2 2024 | $197.2M | -5.3% |
SFNC's revenue has grown year over year for seven quarters in a row: $251M last quarter, up 17% from the same quarter a year ago.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
SFNC has the stronger cash trend. Its trailing FCF is up 4.5% versus its history, compared with IREN at down 479%.
SFNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $125.5M | +89% |
| Q1 2026 | $34M | +50% |
| Q4 2025 | $105.7M | +46% |
| Q2 2025 | $66.3M | -8.8% |
| Q1 2025 | $22.6M | -53% |
| Q4 2024 | $72.3M | -83% |
| Q3 2024 | $187.7M | +$234M |
| Q2 2024 | $72.7M | +40% |
SFNC's free cash flow was $324M over the past year, down 7.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like SFNC.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
SFNC Net Leverage
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
SFNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.4 | Neutral |
| Stochastic | 57.2 | Neutral |
SFNC's weekly RSI is 57 (neutral) and its Stochastic is 57 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
SFNC PE vs Financial Services Sector
| Metric | SFNC | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 12% above |
| PE % | 79 | 63 | 16 pts above |
SFNC is trading at 15x earnings, a 12% premium to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
SFNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.0 | 1.9% above |
| 20 week MA | $23.1 | 1.3% above |
| 50 week MA | $21.5 | 8.8% above |
| 100 week MA | $20.7 | 13% above |
| 200 week MA | $19.9 | 18% above |
SFNC has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
SFNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.8 | $21.1 | -21% |
| 2021 | $21.1 | $29.3 | +39% |
| 2022 | $29.3 | $21.5 | -27% |
| 2023 | $21.5 | $19.8 | -7.7% |
| 2024 | $19.8 | $22.4 | +13% |
| 2025 | $22.4 | $19.2 | -14% |
| 2026 YTD | $19.2 | $23.4 | +22% |
SFNC has the edge over IREN on returns for 2026, with the stronger performance.